Sign In
Buy LLY
$1,156.63
+2.36 (+0.204%)
At Close: Jul 15, 2026
Eli Lilly nears deal to buy psychedelic drugmaker AtaiBeckley, Bloomberg News reports
07:08pm, Wednesday, 15'th Jul 2026
Eli Lilly is in talks to acquire psychedelic drugmaker AtaiBeckley , and a deal could be announced as soon as this week, Bloomberg News reported on Wednesday, citing people
RHHBY's Gazyva Gets FDA Priority Review for Label Expansion
01:10pm, Wednesday, 15'th Jul 2026
Roche wins FDA Priority Review for Gazyva in primary membranous nephropathy, with a decision due by November 2026 after positive phase III data.
Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data
11:55am, Wednesday, 15'th Jul 2026
BIIB's Alzheimer's drug data presentation reaffirms a phase II setback as investors weigh plans to advance diranersen in phase III despite missed goals.
It's been three months since Lilly launched its obesity pill. Most people are taking Novo's pill instead.
08:00pm, Tuesday, 14'th Jul 2026
The market leader in obesity shots, Lilly hasn't made a major dent in the pill market yet.
Eli Lilly (LLY) Stock Dips While Market Gains: Key Facts
06:45pm, Tuesday, 14'th Jul 2026
Eli Lilly (LLY) reached $1 at the closing of the latest trading day, reflecting a -2.48% change compared to its last close.
Healthcare ETFs to Buy as JNJ Beats the Market With a 25% YTD Surge
10:56am, Tuesday, 14'th Jul 2026
JNJ's 25% year-to-date surge and recent FDA approval fuel interest in healthcare ETFs with diversified sector exposure.
Is Lilly Stock On Track To Hit $2,090?
10:30am, Tuesday, 14'th Jul 2026
This article was written by Doug Nathman, with research by his team at Trefis.
Is This Disturbing Trend Bad News for Eli Lilly in the Billion-Dollar Obesity Drug Market?
06:10am, Tuesday, 14'th Jul 2026
Eli Lilly is the leader in the weight loss drug market -- a market on track to reach almost $100 billion. The company's weight loss drugs have delivered tremendous growth in recent years.
Prediction: 1 New Reason Eli Lilly Stock Could Still Be Headed Higher
02:00pm, Monday, 13'th Jul 2026
Eli Lilly (NYSE:LLY | LLY Price Prediction) has whipsawed shareholders in 2026, but the setup heading into the second half looks compelling.
Eli Lilly Stock in Focus as Company Presents New Kisunla Data at AAIC Following Wave of Analyst Upgrades
08:49am, Monday, 13'th Jul 2026
Eli Lilly and Company (NYSE:LLY) shares are in the spotlight Monday as the company presents new data at the Alzheimer's Association International Conference in London. Wall Street weighed in on the st
Here's How Much Eli Lilly's Weight-Loss Drugs Are Worth to Investors
04:23am, Monday, 13'th Jul 2026
Mounjaro and Zepbound combined for $12.8 billion of Lilly's $19.8 billion in first-quarter revenue. Worldwide Mounjaro revenue jumped 125% year over year in the first quarter.
Should You Buy Eli Lilly Stock? Here's My Honest Take.
04:44am, Saturday, 11'th Jul 2026
Lilly's business is booming. However, there is a bear case against the pharma stock.
Eli Lilly's $400 Billion Surge Is Reshaping Big Pharma
02:28pm, Thursday, 09'th Jul 2026
Roughly $400 billion. That is how much market value Eli Lilly (NYSE:LLY | LLY Price Prediction) has added over the past year, with shares climbing from $773.86 on July 2, 2025 to $1,213.91 on July 2,
Stocks Look Shaky, But This Sector is Booming (Biotech)
02:06pm, Thursday, 09'th Jul 2026
Biotechnology stocks like Illumina, Eli Lilly and Exelixis have quietly turned into the new market leaders.
Two Drugmakers Own 90% of the Obesity Boom. One Fund Owns Both for 0.59%
12:18pm, Thursday, 09'th Jul 2026
The Health Care Select Sector SPDR Fund (NYSEARCA:XLV) is the default healthcare allocation for millions of investors, and for good reason.
